RAB0204
人GDF-15 / MIC-1 ELISA试剂盒
for serum, plasma, cell culture supernatant and urine
别名:
GDF-15, Growth/differentiation factor 15 , MIC-1, Macrophage inhibitory cytokine 1
登录 查看组织和合同定价。
选择尺寸
关于此项目
NACRES:
NA.32
UNSPSC Code:
41116158
Gene information:
human ... GDF15(9518)
Input:
sample type cell culture supernatant(s)
sample type serum
sample type plasma
sample type urine
sample type serum
sample type plasma
sample type urine
Species reactivity:
human
Storage temp.:
−20°C
Shipped in:
wet ice
产品名称
人GDF-15 / MIC-1 ELISA试剂盒, for serum, plasma, cell culture supernatant and urine
species reactivity
human
packaging
kit of 96 wells (12 strips x 8 wells)
technique(s)
ELISA: suitable
capture ELISA: suitable
input
sample type cell culture supernatant(s)
sample type serum
sample type plasma
sample type urine
assay range
inter-assay cv: <12%
intra-assay cv: <10%
sensitivity: 2 pg/mL
standard curve range: 1.1-800 pg/mL
detection method
colorimetric
shipped in
wet ice
storage temp.
−20°C
Gene Information
human ... GDF15(9518)
Application
人生长分化因子15/巨噬细胞抑制因子1(GDF-15/MIC-1)ELISA（酶联免疫吸附测定）试剂盒已用于定量测定静脉血样本中的循环巨噬细胞抑制因子-1(MIC-1)。
仅供研究使用。不可用于诊断操作。
请参考附带的一般ELISA试剂盒操作程序（夹心、竞争性 & 间接ELISA）
请参考附带的一般ELISA试剂盒操作程序（夹心、竞争性 & 间接ELISA）
General description
人生长分化因子15/巨噬细胞抑制因子1(GDF-15/MIC-1)的ELISA（酶联免疫吸附测定）试剂盒通过体外酶联免疫吸附技术定量测定血清、血浆、细胞培养物上清、尿液或细胞和组织裂解液等生物样本中的目标蛋白。生长分化因子15(GDF-15)是应激反应的细胞因子。在炎症反应和组织损伤过程中浓度升高。GDF-15与代谢性心血管病风险有关。它位于脂肪细胞、巨噬细胞、心肌细胞和血管平滑肌细胞中。
Immunogen
重组人GDF15
Other Notes
本产品提供样本检验报告。
请在批号对应的文本框中输入样品 一词。
请在批号对应的文本框中输入样品 一词。
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
存储类别
8A - Combustible corrosive hazardous materials
法规信息
低风险生物材料
常规特殊物品
此项目有
Opposing effects of PI3K/Akt and Smad-dependent signaling pathways in NAG-1-induced glioblastoma cell apoptosis.
Zhang Z
PLoS ONE, 9(4), e96283-e96283 (201)
Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs.
Bloch SA
Thorax, 70(3), 219-228 (2015)
Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications 2015.
Joseph Fomusi Ndisang et al.
Journal of diabetes research, 2015, 234135-234135 (2015-08-21)
Sébastien Jeay et al.
Cancer research, 78(21), 6257-6267 (2018-08-24)
Activation of p53 by inhibitors of the p53-MDM2 interaction is being pursued as a therapeutic strategy in p53 wild-type cancers. Here, we report distinct mechanisms by which the novel, potent, and selective inhibitor of the p53-MDM2 interaction HDM201 elicits therapeutic
Insulin resistance, type 1 and type 2 diabetes, and related complications 2015
Ndisang J F, et al.
Journal of Diabetes Research (2015)
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持